lithium carbonate has been researched along with Fra(X) Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berry-Kravis, E; Greenough, WT; Hervey, C; Nelson, M; Porges, SW; Sumis, A; Weiler, IJ; Weng, N | 1 |
| Chuang, DM; Liu, ZH; Smith, CB | 1 |
| Beurel, E; Jope, RS; Yuskaitis, CJ | 1 |
1 trial(s) available for lithium carbonate and Fra(X) Syndrome
| Article | Year |
|---|---|
Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome.
Topics: Administration, Oral; Adolescent; Adult; Antidepressive Agents; Blood Cell Count; Child; Cognition; Extracellular Signal-Regulated MAP Kinases; Fragile X Syndrome; Humans; Learning; Lithium Carbonate; Pilot Projects; Psychiatric Status Rating Scales; Psychological Tests; Receptors, Metabotropic Glutamate; Thyrotropin; Treatment Outcome | 2008 |
2 other study(ies) available for lithium carbonate and Fra(X) Syndrome
| Article | Year |
|---|---|
Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.
Topics: Animals; Anxiety; Behavior, Animal; Body Weight; Dendritic Spines; Disease Models, Animal; Enzyme Inhibitors; Female; Fragile X Mental Retardation Protein; Fragile X Syndrome; Genotype; Humans; Lithium Carbonate; Male; Maze Learning; Mice; Mice, Knockout; Motor Activity; Prefrontal Cortex | 2011 |
Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome.
Topics: Animals; Astrocytes; Brain; Cytokines; Disease Models, Animal; Female; Fragile X Mental Retardation Protein; Fragile X Syndrome; Glial Fibrillary Acidic Protein; Glycogen Synthase Kinase 3; Immune System; Immunoblotting; Lithium Carbonate; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Phosphorylation; Serine; Testis | 2010 |